About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1NCT04722653

A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian Men

This study looks at how a new medicine called NNC0194-0499 works in the body of Japanese men and non-Asian men. Japanese participants will either get NNC0194-0499 or placebo - which treatment partici...

Lead sponsor: Novo Nordisk A/S•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Novo Nordisk A/S

Age

20 - 55 years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Male, aged 20-55 years (both inclusive) at the time of signing informed consent
•For Japanese subjects only, both parents of Japanese descent. For non-Asian subjects only, both parents of non-Asian descent
•Body mass index (BMI) between 23.0 and 34.9 kg/m\^2 (both inclusive)
•Body weight greater than or equal to 60 kg

Exclusion Criteria

•Any disorder which in the investigator's opinion might jeopardise subject's safety or compliance with the protocol
•Subjects aged above or equal to 40 years with an estimated 10-year atherosclerotic cardiovascular disease risk (as described in the American College of Cardiology and the American Heart Association Prevention Guideline) greater than or equal to 5 percentage

Related studies

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

NCT05623150 · Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, and more

Identification of Liver Fibrosis Biomarkers

NCT06819917 · Non-alcoholic Fatty Liver, Non-Alcoholic Fatty Liver Disease, and more

Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

NCT06661655 · Metabolic Syndrome X, Fatty Liver, and more

Longitudinal Observational Study Of Chinese With NAFLD/NASH

NCT03151473 · Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH)

Enrolling By InvitationNA

Reducing Non-Alcoholic Steatohepatitis

NCT06519448 · Non-alcoholic Steatohepatitis, Liver Diseases, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 5, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment42

Start dateFeb 2021

Last updatedApr 5, 2022

Condition

Non-alcoholic Steatohepatitis

Locations shown

Novo Nordisk Investigational Site

Tokyo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 5, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions